20cm速递｜创业板医药ETF国泰（159377）微幅回调超0.5%，行业集中度有望加速提升，回调或可布局

Group 1 - The core viewpoint of the article is that the Ministry of Commerce and eight other departments have jointly issued opinions to promote the high-quality development of the pharmaceutical retail industry, focusing on transforming the industry from "selling drugs" to "health services" [1] - The policy encourages mergers, acquisitions, and horizontal integration, which is expected to accelerate the clearing of individual pharmacies and enhance industry concentration [1] - The optimization of external prescription review and the establishment of pharmacy service platforms are aimed at facilitating prescription outflow and expanding the market [1] Group 2 - Retail pharmacies are encouraged to broaden their business scope to include health consultations, traditional Chinese medicine culture, and elderly care services, thereby creating comprehensive health service platforms [1] - The ChiNext Medical ETF (159377) tracks the ChiNext Medical Index (399275), which includes listed companies in the biopharmaceutical, medical device, and healthcare service sectors, reflecting the overall performance of the pharmaceutical industry on the ChiNext market [1]